Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Safety and PK of TAK-438 in Healthy Japanese Men
NCT02123927Phase 1Completed
- Sponsor
- Takeda
- Start
- Sep 2007
- Primary completion
- Dec 2007
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of vonoprazan in acid peptic disorder (APD) (11 arms), sponsored by Takeda. Primary endpoints: Number of Participants With Treatment-Emergent Adverse Events, Number of Participants With Potentially Clinically Significant Vital Sign Findings and 4 more. Started Sep 2007; status: completed.
02
Drugs
vonoprazan
03
Conditions
acid peptic disorder (APD)
Beyond the preview
Go deeper on NCT02123927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02123927.